Fig. 4From: Detection of HER2 expression using 99mTc-NM-02 nanobody in patients with breast cancer: a non-randomized, non-blinded clinical trial18F-FDG PET/CT and 99mTc-NM-02 SPECT/CT of Patient BR014 and Patient BR037 at 1Ā h post-injectionBack to article page